CERN Cerner Corporation featured news, full reports, and detailed charts
Cerner Corporation (CERN) Wrap Up:
Cerner Corporation (“Cerner” or the “Company”) is a Delaware business corporation formed in 1980. The Company’s corporate headquarters are located at 2800 Rockcreek Parkway, North Kansas City, Missouri 64117. Its telephone number is 816.221.1024. The Company’s Web site address is www.cerner.com. The Company makes available free of charge, on or through its Web site, its annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities and Exchange Commission. Cerner is a supplier of healthcare information technology (HIT) solutions, healthcare devices and related services. Organizations ranging from single-doctor practices, to hospitals, to corporations, to local, regional and national government agencies use Cerner® solutions and services to make healthcare safer, more efficient and of higher quality. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f02%2f27%2f0000950137-08-002851.html#FIS_BUSINESS"Cerner Corp. (CERN:NASDAQ)
Snapshot of Cerner Corp. (CERN)
|
OPEN
$75.74
|
PREVIOUS CLOSE
$75.88
|
|
|
DAY HIGH
$76.06
|
DAY LOW
$75.15
|
|
|
52 WEEK HIGH
10/14/09 - $85.97
|
52 WEEK LOW
11/21/08 - $30.37
|
|
|
MARKET CAP
6.2B
|
AVERAGE VOLUME 3 mo
704.2K
|
|
|
DILUTED EPS TTM
$2.48
|
SHARES OUTSTANDING
81.6M
|
|
|
CERN Does Not Pay Dividends
|
P/E TTM
30.6x
|
|
| K = Thousands M = Millions B = Billions | ||
related news
related news
CERN Top Compensated Officers
Executives, Board Directors
Key developments for Cerner Corp. (CERN)
Cerner Corp. announced earnings results for the third quarter and nine months ended October 3, 2009. For the quarter, the company reported total revenue of $409,415,000 compared to $422,728,000 for the same period last year. Operating earnings was $70,710,000 compared to $67,751,000 for the same period last year. Earnings before income taxes were $70,887,000 compared to $67,958,000 for the same period last year. On GAAP basis net earnings were $48,394,000 or $0.60 basic per share compared $45,014,000 or $0.54 basic per share for the same period last year. Adjusted net earnings were $51,346,000 or $0.57 diluted per share compared to $47,449,000 or $0.54 diluted per share for the same period last year same period. For the nine months, the company reported total revenue of $1,205,543,000 compared to $1,210,293,000 for the same period last year. Operating earnings was $198,846,000 compared to $177,438,000 for the same period last year. Earnings before income taxes were $198,973,000 compared to $178,965,000 for the same period last year. On GAAP basis net earnings were $132,969,000 or $1.65 basic per share compared $117,118,000 or $1.45 basic per share for the same period last year. Adjusted net earnings were $140,631,000 or $1.59 diluted per share. The company provided earnings guidance for the fourth quarter of 2009. For the quarter, the company expected adjusted diluted earnings per share before stock options expense between $0.68 and $0.74. SFAS No. 123R share-based compensation expense to reduce diluted earnings per share by approximately $0.03 to $0.04 in the fourth quarter of 2009.
Cerner Corp. expected to Report Fiscal Year 2009 Results on February 8, 2010. This event was calculated by Capital IQ (Created on October 28, 2009).
Cerner Corp. reported cash flow and capital expenditure for the third quarter and nine months of 2009. The company reported that operating cash flow for the quarter was solid at $73 million. Capital expenditures were $24 million. This brings year-to-date free cash flow to $91 million, which is strong growth compared to $58 million in the first three quarters of 2008. The company provided earnings guidance for the fourth quarter and full year of 2009 a. The company expects revenue in the $435 to $465 million range which is strong sequential increase from third quarter and reflects expectation that will see a seasonally strong fourth quarter and increasing stimulus driven demand. The company expects EPS before options expense to be $0.68 to $0.74 per share, also reflecting a strong sequential increase compared to third quarter. The company to exceed target of $100 million on free cash flow in 2009.
CERN Competitors
| Company | Last | Change |
| Allscripts-Misys Healthcre Solutions Inc | $20.07 USD | -0.29 |
| CGI Group Inc | C$12.87 CAD | -0.03 |
| DST Systems Inc | $41.97 USD | -0.42 |
| Jack Henry & Associates Inc | $23.31 USD | +0.01 |
| SEI Investments Co | $17.66 USD | -0.12 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | CERN | Industry Range |
| Price/Earnings | 30.9x |
|
| Price/Sales | 3.7x |
|
| Price/Book | 4.1x |
|
| Price/Cash Flow | 30.3x |
|
| TEV/Sales | 3.4x |
|
|
CERN |
||
CERN transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
